Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02652260 |
|---|---|
| Brief Title: | Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) |
| First Submitted : | January 8, 2016 |
| First Submitted that Met QC Criteria : | January 8, 2016 |
| First Posted : | January 11, 2016 (Estimate) |
| Results First Submitted : | July 16, 2019 |
| Results First Submitted that Met QC Criteria : | August 26, 2019 |
| Results First Posted : | August 29, 2019 |
| Last Update Submitted that Met QC Criteria : | September 14, 2022 |
| Last Update Posted : | September 27, 2022 |